Show simple item record

dc.contributor.authorAL-MARRI, A.
dc.contributor.authorBener, Abdulbari
dc.contributor.authorMORAD, N.
dc.contributor.authorYAKOOB, R.
dc.contributor.authorAMER, A. M.
dc.contributor.authorDERBALA, M. F.
dc.contributor.authorAL KAABI, S. R.
dc.contributor.authorEL DWEIK, N. Z.
dc.contributor.authorPASIC, F.
dc.contributor.authorBUTT, M. T.
dc.date.accessioned2021-03-03T15:02:20Z
dc.date.available2021-03-03T15:02:20Z
dc.date.issued2006
dc.identifier.citationDERBALA M. F. , AL KAABI S. R. , EL DWEIK N. Z. , PASIC F., BUTT M. T. , YAKOOB R., AL-MARRI A., AMER A. M. , MORAD N., Bener A., "Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: Impact of bilharziasis and fibrosis stage", WORLD JOURNAL OF GASTROENTEROLOGY, cilt.12, sa.35, ss.5692-5698, 2006
dc.identifier.issn1007-9327
dc.identifier.otherav_3cdbdfc8-13e6-4686-ac95-1a2831bc7d5e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/44820
dc.identifier.urihttps://doi.org/10.3748/wjg.v12.i35.5692
dc.description.abstractAIM: To evaluate pegylated interferon alpha2a (PegIFN-alpha 2a) in Egyptian patients with HCV genotype 4, and the impact of pretreatment viral load, co-existent bilharziasis and histological liver changes on response rate.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleTreatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: Impact of bilharziasis and fibrosis stage
dc.typeMakale
dc.relation.journalWORLD JOURNAL OF GASTROENTEROLOGY
dc.contributor.department, ,
dc.identifier.volume12
dc.identifier.issue35
dc.identifier.startpage5692
dc.identifier.endpage5698
dc.contributor.firstauthorID95953


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record